Tango Therapeutics Inc (TNGX) USD0.0001

Sell:$1.42Buy:$1.48No change

Prices delayed by at least 15 minutes
Sell:$1.42
Buy:$1.48
Change:No change
Prices delayed by at least 15 minutes
Sell:$1.42
Buy:$1.48
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company's novel small molecules are designed to be selectively active in cancer cells with specific genetic alterations, killing those cancer cells while sparing normal cells. It is also extending its target space beyond the classic, cell-autonomous effects of tumor suppressor gene loss. It is engaged in developing two methylthioadenosine (MTA)-cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors: TNG462 for non- central nervous system (CNS) cancers, including pancreatic and lung cancer, and TNG456, brain-penetrant PRMT5 inhibitor, for CNS cancers, including glioblastoma (GBM). Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor, which in preclinical studies reversed the immune evasion effect of STK11 loss-of-function mutations.

Key people

Barbara Weber
President, Chief Executive Officer, Director
Daniella Beckman
Chief Financial Officer
Adam S. Crystal
President - Research and Development
Julie Carretero
Chief Human Resource Officer
Douglas Barry
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary
Alexis Borisy
Independent Chairman of the Board
Lesley Ann Calhoun
Independent Director
John Ketchum
Independent Director
Malte Peters
Independent Director
Kanishka Pothula
Independent Director
Click to see more

Key facts

  • EPIC
    TNGX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US87583X1090
  • Market cap
    $158.92m
  • Employees
    155
  • Shares in issue
    108.11m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.